Biotek-snakken — Juni 2021
-
Det med småt - Fast Track been granted for patients without actionable mutations, with
disease progression on or after treatment with an anti-PD-(L)-1 agent, with or
without chemotherapy as their first line of therapy. Ser desværre ud til FT kun dækker relapsed PD-(L)-1pts. Ville give mere mening at den dækkede kombien i PD-(L)-1 näive pts ?? -
Biogen udvider ansøgning om alzheimer-godkendelse efter FDA-ja -
NYhttps://www.proinvestor.com/investornyt/675835/biogen-udvider-ansogning-om-alzheimer-godkendelse-efter-fda-ja-ny -
-
Sikke en stigning idag, Jazzz….kan ikke finde nyheder, så markedet må have set det,
vi så for lang tid siden
eller hvad sker der? -
US: Biotech og health care stærk positiv bevægelse modsat negativt marked https://www.proinvestor.com/investornyt/675890/us-biotech-og-health-care-staerk-positiv-bevaegelse-modsat-negativt-marked
-
Har også et godt øje på Acarix, Jazz….har du et bud på hvor stort salget kan blive og nogle estimater på hvornår der evt kan forventes en grøn bundlinje?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind